コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 DC-SIGN (dendritic cell-specific intercellular adhesion
2 DC-SIGN (SIGN-R1) is present on mouse lung epithelial ce
3 DC-SIGN also was shown to play a role in the infection o
4 DC-SIGN and CD206 nanodomains are randomly distributed o
5 DC-SIGN efficiently reduces the amount of gp120 present
6 DC-SIGN forms remarkably stable microdomains on the plas
7 DC-SIGN has high affinity for fucosylated glycans in sev
8 DC-SIGN is a dendritic cell surface structure which part
9 DC-SIGN is a major receptor for infection of both monocy
10 DC-SIGN is thought to be crucial for the development of
11 DC-SIGN nanoclusters exhibited free, Brownian diffusion
12 DC-SIGN, a Ca(2+)-dependent transmembrane lectin, is fou
13 DC-SIGN-blocking assays were performed by incubating DCs
14 DC-SIGN-targeted transduction occurs in the presence of
15 frequency and microbiome of CD19(-)BDCA-1(+)DC-SIGN(+) blood myeloid DCs (mDCs) were analyzed in CP
18 tion and decreased T cell proliferation in a DC-SIGN-, glycosylation-, and Raf1-dependent manner.
29 inhibiting gp120 interactions with 2G12 and DC-SIGN and blocking 2G12-mediated neutralization of HIV
36 f HCV-induced CD68 and M2 markers (CD206 and DC-SIGN) in normal monocytes was further enhanced in the
37 mong the inflammatory markers, only CD68 and DC-SIGN were significant prognostic factors in univariat
38 nhibitory receptors (FcRL5, FcgammaRIIb, and DC-SIGN) with high avidity and specificity, whilst elimi
43 s indicate that the CRDs of both SIGN-R1 and DC-SIGN bind to a restricted set of primarily oligomanno
45 The genes encoding OAS1, OAS2, TLR3, and DC-SIGN, which mediate antiviral innate immunity, were w
48 ceptors because only the combination of anti-DC-SIGN and low-molecular-weight heparin prevented bindi
49 blocked, in part, by Raf-1 inhibitor or anti-DC-SIGN antibodies and was significantly reduced in cell
51 of HIV-1 attachment factors (HAFs), such as DC-SIGN, heparan sulfate proteoglycan (HSPG), and alpha4
53 DC-SIGN and DC-SIGNR (collectively termed as DC-SIGN/R) using a sensitive, ratiometric Forster resona
59 of glycomimetic compounds were able to block DC-SIGN-dependent HIV infection in cervical explant mode
63 led to endocytosis in vitro as expected, but DC-SIGN, even when cross-linked, did not lead to signifi
64 further intracellular pathways activated by DC-SIGN in a range of primary FL cells with detection of
69 alled MDDC differentiation, as quantified by DC-SIGN/CD14 expression ratios, showing cooperative invo
70 ht differences between pathogen targeting by DC-SIGN and receptors in which binding sites at fixed sp
73 Conversely, in preeclampsia, both CD14(+)DC-SIGN(+) and CD14(+)DC-SIGN(-) APCs induced iTreg cell
75 These results suggest that decidual CD14(+)DC-SIGN(+) APCs may play important roles in iTreg cell i
81 CD206/macrophage mannose receptor and CD209/DC-SIGN, as well as costimulatory molecules CD86 and CD4
83 HIV-1 gp120-specific attachment factors CD4, DC-SIGN, and syndecans, were attenuated in their ability
84 s of DCs is based on the expression of CD83, DC-SIGN, and DC-LAMP, which are nonspecific markers of D
87 e 2 is the functional receptor for SARS-CoV; DC-SIGN and CD209L (L-SIGN) can enhance viral entry.
95 ut not in B-cell lines transduced to express DC-SIGN lacking the transmembrane domain, demonstrating
96 es from peripheral blood and tonsils express DC-SIGN and that this expression increases after B-cell
97 dendritic cells (DCs), many of which express DC-SIGN (DC-specific ICAM-3 grabbing nonintegrin; CD209)
98 of feline monocyte-derived cells expressing DC-SIGN, indicating a role for FIPV infection in vivo.
104 ligomannose glycans are also the ligands for DC-SIGN, a C-type lectin found on the surface of dendrit
105 ssentially undetectable lateral mobility for DC-SIGN but an appreciable mobility for HA within their
107 ereas oligomannose-type glycans required for DC-SIGN-dependent cellular attachment are predominant on
108 ther, our data support an important role for DC-SIGN-expressing infiltrating cells in the biology of
110 ment of the cells with antibody specific for DC-SIGN or with mannan but not antibody specific for xCT
112 which are CD11b(+)F4/80(+)CD11c(+)MHCII(high)DC-SIGN(high)Ly6c(+) and express high levels of CCR5, CX
113 ls can be rescued by the expression of human DC-SIGN (hDC-SIGN) and that infection of a permissive fe
116 In this study, stably transfected human DC-SIGN(+/-) Raji cell lines and monocyte-derived DCs (M
117 taining glycopolymers to interact with human DC-SIGN and the ability of these glycopolymers to inhibi
119 s response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-i
121 fects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators
123 ests how CRDs may be disposed differently in DC-SIGN compared with DC-SIGNR and in variant forms of D
124 C-terminal C-type CRDs, the neck domains in DC-SIGN and DC-SIGNR act as autonomous tetramerization d
125 s of the carbohydrate-recognition domains in DC-SIGN and DC-SIGNR result from variations in the seque
128 used gene silencing to specifically inhibit DC-SIGN expression by DCs followed by allergen uptake st
130 DC-specific ICAM-3 -: grabbing non integrin (DC-SIGN) and macrophage mannose receptor 1 (MMR-1).
131 to DC-specific ICAM3-grabbing non-integrin (DC-SIGN) and its related receptor, L-SIGN, were found.
132 r adhesion molecule-3 grabbing non-integrin (DC-SIGN) and mannose receptor, bound to FL surface immun
133 r adhesion molecule-3-grabbing non-integrin (DC-SIGN) on DCs as early as day 2 and continuing through
134 r adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription fac
135 r adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), CD123, neutrophil elastase, CD31, and carbonic
138 by the internalization of P. gingivalis into DC-SIGN-rich intracellular compartments, and MoDCs secre
139 ore, we asked whether RSV infection involves DC-SIGN (CD209) or its isoform L-SIGN (CD299) (DC-SIGN/R
140 of the feline homologue to the human lectin DC-SIGN and show that it is a coreceptor for virulent st
141 tion domain (CRD) of the cell-surface lectin DC-SIGN (dendritic cell-specific intercellular adhesion
142 ty binding to the human transmembrane lectin DC-SIGN and act as inhibitors to prevent the binding of
143 G-I and Mda5 by activating the C-type lectin DC-SIGN and inducing signaling that prevents RLR dephosp
145 en a human dendritic cell associated lectin (DC-SIGN) and the viral envelope glycoprotein gp120.
148 rmore, CV-N competed with the C-type lectins DC-SIGN and mannose receptor for ligand binding and inhi
149 l, SARS-CoV is thought to use C-type lectins DC-SIGN and/or L-SIGN (collectively referred to as DC/L-
150 cell lines transduced to express full-length DC-SIGN but not in B-cell lines transduced to express DC
152 studies using Fc chimeras revealed that LRP, DC-SIGN, and mannose receptor can bind to FVIII; however
153 s in the healthy human brain through the MOG-DC-SIGN homeostatic regulatory axis, which is comprised
154 ular adhesion molecule-grabbing nonintegrin (DC-SIGN) (CD209) receptor, expressed by APCs, to be capt
155 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN) and heparan sulfate proteoglycan were implicate
156 ar adhesion molecule 3-grabbing nonintegrin (DC-SIGN) and the macrophage galactose lectin, to glycopr
157 ion molecule 3 (ICAM3) grabbing nonintegrin (DC-SIGN) leads to a reduction in the expression of Toll-
159 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, typ
162 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), and TLR4 because ActApo-induced up-regulation
163 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), mannose-binding lectin, and heparan sulfate, e
164 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN), which could in turn trigger delayed but long-l
169 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN, CD209), Dectin-1, Toll-like receptors (TLRs), c
170 hat ES targets DC-specific ICAM nonintegrin (DC-SIGN) to survive in myeloid DCs for which outer membr
172 stimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T c
173 urther confirmed by its specific blocking of DC-SIGN engagement with the Ebola virus glycoprotein.
174 prehensive report on the characterization of DC-SIGN-binding proteins in common allergenic foods such
177 ayers displaying the extracellular domain of DC-SIGN and a neoglycolipid bearing an oligosaccharide l
178 In the work reported here, neck domains of DC-SIGN and DC-SIGNR expressed in isolation are shown to
179 ET treatment results in downregulation of DC-SIGN, a marker of immature DCs, and upregulation of D
180 ersely correlated with surface expression of DC-SIGN (DC-specific intercellular adhesion molecule-3-g
181 th HHV-8 resulted in increased expression of DC-SIGN and a decrease in the expression of CD20 and maj
182 rate that cocaine induces over expression of DC-SIGN and significantly enhances virus transfer from D
184 in on LC but downregulated the expression of DC-SIGN on iDDC, as we previously reported for MDDC.
185 This profile is enhanced by expression of DC-SIGN on MoDCs and minor mfa-1 fimbriae on P. gingival
187 s of CD209e (DC-SIGNR4), a murine homolog of DC-SIGN, were increased in the lungs of HDM-challenged V
188 In addition, differences in the lengths of DC-SIGN and DC-SIGNR extracellular domains with equivale
189 eas immature DC, expressing higher levels of DC-SIGN and similar FcgammaRIIa levels, did not undergo
191 luence the nanoscale lateral organization of DC-SIGN but restrict the mobility of the receptor to dis
192 he absence of Ca(2+) and by preincubation of DC-SIGN with mannan, suggesting that C1q binds to DC-SIG
193 thrin, thereby increasing the probability of DC-SIGN-clathrin interactions beyond random encountering
197 hus, HIV sequestration by and stimulation of DC-SIGN helps HIV evade immune responses and spread to c
198 ains to Raji cells and MoDCs is dependent on DC-SIGN, whereas the double fimbriae mutant strain does
203 versatility in entry routes (FcgammaRIIa or DC-SIGN) in mature DC broadens target options and sugges
205 ctin domains of the mannose receptor (MR) or DC-SIGN bind mannosylated Igs in vitro and bind to FL ce
206 iated knockdown of LRP, mannose receptor, or DC-SIGN expression in monocyte-derived dendritic cells d
208 k regions, and receptor diffusion to provide DC-SIGN with the exquisite ability to dock pathogens at
210 f the dendritic cell glycan-binding receptor DC-SIGN and the closely related endothelial cell recepto
211 Targeting of myeloid-dendritic cell receptor DC-SIGN by numerous chronic infectious agents, including
214 fimbria, targets the C-type lectin receptor DC-SIGN for invasion and persistence within human monocy
215 cells expressing the C-type lectin receptor DC-SIGN, persisted at sites of HSV-2 reactivation for mo
217 port that SAP but not CRP binds the receptor DC-SIGN (SIGN-R1) to affect the innate immune system, an
218 mains (CRDs) in the glycan-binding receptors DC-SIGN (dendritic-cell-specific intercellular adhesion
219 tivalent interactions of HIV/Ebola receptors DC-SIGN and DC-SIGNR (collectively termed as DC-SIGN/R)
220 gens and on mammalian cells by the receptors DC-SIGN (CD209) and DC-SIGNR (L-SIGN, CD299) is dependen
222 Indeed, removal of fucose on myelin reduced DC-SIGN-dependent homeostatic control, and resulted in i
228 1-grabbing nonintegrin; CD209) and DC-SIGNR (DC-SIGN-related receptor, also known as L-SIGN and vario
229 Intriguingly, our data showed that silencing DC-SIGN on DCs promotes a Th2 phenotype in DC/T cell co-
238 ingle particle tracking, we demonstrate that DC-SIGN intrinsic nanoclustering strictly depends on its
243 the QD surface mannose valency reveals that DC-SIGN binds more efficiently to densely packed mannosi
247 receptors on DCs and strongly suggests that DC-SIGN plays a critical role in HTLV-1 binding, transmi
249 onfirmed that the minor fimbria contains the DC-SIGN-targeting carbohydrates fucose (1.35 nmol/mg), m
251 himeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that
254 and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for it
255 for the complete extracellular region of the DC-SIGN tetramer was similar for all antibody glycoforms
258 ay contain other C-type lectins and that the DC-SIGN cytoplasmic region is not required for microdoma
259 DC differentiation and function through the DC-SIGN-mediated induction of cell-signaling pathways.
264 ctivation of human DCs by LPS via binding to DC-SIGN and MMR-1, leading to attenuated TLR signaling.
265 of gp120 also exhibited decreased binding to DC-SIGN in the context of native envelope spikes on a vi
268 id (aa) 196 and E1 aa 139 mediate binding to DC-SIGN, which supports the results of a previous report
271 GN with mannan, suggesting that C1q binds to DC-SIGN at its principal Ca(2+)-binding pocket, which ha
275 as confirmed by binding of soluble BTN2A1 to DC-SIGN-transfectants and its inhibition by a specific A
278 herapy does not involve binding of IgG Fc to DC-SIGN and that alternative cell-surface lectins are re
280 ferentially deliver the PSCA antigen gene to DC-SIGN-expressing 293T cells and bone marrow-derived DC
283 er full-length nor cytoplasmically truncated DC-SIGN in microdomains appreciably exchanged with like
290 est that allergens are able to interact with DC-SIGN and induce tumor necrosis factor-alpha expressio
291 whether our targeting vectors interact with DC-SIGN, which traps many types of viruses and gene ther
293 non-IgE-binding proteins that interact with DC-SIGN; these proteins may be important for regulating
294 her fucosylation and better interaction with DC-SIGN [DC-specific intercellular adhesion molecule-3 (
296 study that Y. pestis directly interacts with DC-SIGN and invades both DCs and alveolar macrophages.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。